Gastrostomy Tube Feeding Devices Market Size is growing at a steady pace between 2022 and 2028, driven by the growing geriatric population alongside high incidence of chronic conditions throughout the globe. Since insufficient nutrition is associated with high mortality, ICU admissions, as well as longer hospital stays, healthcare establishments are providing early enteral nutrition to critically ill hospitalized patients.
These devices are inserted through the stomach and directly bring the food to the intestine. Since gastrostomy tubes are comparatively easier to use than nasogastric tubes, the percutaneous endoscopic gastrostomy market share is on the rise. These devices are used during outpatient procedures as well, because their use does not require overnight stay.
By age group, the pediatrics segment is likely to command a substantial portion of the gastrostomy tube feeding devices market through the assessment timeline, on account of the rising number of premature births worldwide. During 2020, about 1 in 10 infants was born premature across the United States, as per the data published by the Centers for Disease Control and Prevention (CDC). In Australia, about 8% of the total babies are born prematurely, or before 37 weeks.
According to the WHO, more than 15 million babies across the world are born preterm, with the preterm birth rate ranging between 5 % and 18% across 184 nations. Feeding difficulties are a frequent occurrence amongst preterm and sick babies. They often need gastrostomy feeding nursing procedure, as they are too small or/and sick to be bottle-fed or breastfed at first.
Gastrostomy tube feeding devices market for the neurological disorders segment is expected to record a notable increase through 2028. Weight loss and malnutrition are common amongst patients with motor neuron disease, Alzheimer’s, Parkinson’s, and other neurological disorders. In order to minimize the risk of mortality, morbidity, and disability amongst these patients, interventional nutritional support using these feeding devices is provided by healthcare personnel.
Due to the pandemic, several patients have been relying on home enteral nutrition. As such, the industry share from the home care segment is slated to witness a marked rise over the analysis timeline. All major healthcare establishments provide assistance of a home enteral nutrition (HEN) care team, which teaches patients to feed themselves and help them when they face any technical issues.
Europe gastrostomy tube feeding devices market is anticipated to grow substantially over 2028, owing to the rising geriatric population across Germany, U.K., Sweden, Bulgaria, and Italy. According to the statistics revealed by European Commission’s Joint Research Commission, over 2.7 million new cancer cases alongside 1.3 million deaths were recorded during 2020.
The high burden of cancer across EU-27 countries is facilitating product uptake across enteral feeding devices market. This is because cancer patients often struggle to maintain a proper nutrition. If a person has cancer in the neck or head area, they can have trouble swallowing food. Many cancer patients are malnourished during or before cancer treatment, such as chemotherapy, surgery, or radiation therapy. Others might be diagnosed with fistulas or an abscess (an opening) in the esophagus, which makes digestion difficult.
Boston Scientific Corporation, Moog, Halyard Health, Abbott Nutrition, Fresenius Kabi, C.R. Bard, Medtronic, Nestle, and Danone are some leading gastrostomy tube feeding device manufacturers worldwide. They are investing in R&D, entering partnerships, and signing M&As, for claiming a larger market share.
The COVID-19 pandemic has had a positive impact on the gastrostomy tube feeding devices market outlook, owing to the increasing number of hospital complications and ICU admissions. The introduction of new guidelines for nutritional management of patients with SARS-CoV-2 infection by entities such as ESPEN is pushing the industry forecast. As per the recent ESPEN guidelines and expert statements, high-risk hospitalized patients, including older adults and polymorbid individuals, must be screened for malnutrition. These recommendations include the administration of enteral nutrition among high-risk COVID-19 patients whose nutritional requirements cannot be fulfilled orally.
Market, by Product
Market By Age Group, 2013-2024 (USD Million)
Market, by Application
Market, by End-use
The above information is provided for the following regions and countries: